首页> 外文期刊>Macromolecular Research >Particle size reduction of water-insoluble drug in water-assisted extrusion of hydroxypropyl methyl cellulose
【24h】

Particle size reduction of water-insoluble drug in water-assisted extrusion of hydroxypropyl methyl cellulose

机译:羟丙基甲基纤维素水助挤出中水不溶性药物的粒径减小

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recent advances in the preparation of nanoparticles of water-insoluble drugs, while remarkable, still largely require a secondary drying step to produce solid dosage forms. This report describes the novel extrusion of crystalline drug particles in a polymer/water matrix, which was developed as a comminution technique for particle size reduction. Itraconazole and hydroxypropyl methyl cellulose were used as a model drug and a matrix polymer, respectively. Nanocomposites of 400 nm itraconazole crystals were prepared successfully with significantly improved release kinetics. The water and polymer content should be optimized, and the repeated extrusion runs were beneficial for effective particle size reduction. This process produced nanocomposite granules, containing stable crystalline drug particles, which can be processed readily into a solid dosage form with a high drug content without a drying step.
机译:水不溶性药物的纳米颗粒的制备方面的最新进展虽然引人注目,但仍在很大程度上需要二次干燥步骤来制备固体剂型。该报告描述了在聚合物/水基质中结晶药物颗粒的新型挤出方法,该方法是作为粉碎技术用于减小粒径而开发的。伊曲康唑和羟丙基甲基纤维素分别用作模型药物和基质聚合物。成功制备了400 nm伊曲康唑晶体的纳米复合材料,并显着改善了释放动力学。应优化水和聚合物的含量,并且重复挤出操作有利于有效减小粒径。该方法产生了包含稳定的结晶药物颗粒的纳米复合颗粒,可以容易地将其加工成具有高药物含量的固体剂型,而无需干燥步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号